.
.
.
.
Parse Biosciences is now part of QIAGEN, bringing scalable Evercode single-cell sequencing workflows that enable large studies without specialized instruments. Explore the technology.
Clear search
Press Enter to perform search.
0
Order Status
Quick Order
0
icon_0147_cc_gen_global-s
US
Products
Applications & Insights
Knowledge & Support
About QIAGEN
Help Center
Product Finder
Experiment Configurator
Discovery & Translational Research
Diagnostics & Clinical Research
Human ID & Forensics
Next-Generation Sequencing
Instruments & Automation
Informatics & Data
Services
Strategic partnerships
Top Sellers
New Solutions
Shop
Applications & Insights Overview
Applied & Industrial
Research & Technology
Diagnostic & Clinical
Digital Tools & Platforms
Plan your experiment
Strategic partnerships
Knowledge & Support Overview
Service Solutions
Events & Webinars
Knowledge Hub
Quality, Environmental, Health & Safety
Product & Technical Support
Ordering Support
Safety Data Sheets
Product FAQ
About Us
Careers
Investor Relations
Newsroom
Customer stories
Sustainability
Compliance
Contact Us
TB Management
QuantiFERON-TB Gold Plus
Transplant
QuantiFERON Transplant
artus Viral Load
Infectious Disease
QIAstat-Dx Syndromic Testing
Oncology
therascreen Solid Tumor
ipsogen Leukemia
Circulating Tumor Cells
DNA Damage Response
Sexual & Reproductive Health
Cervical Cancer Screening
Maternal/Fetal Testing
STI Testing
Sample Processing
Solutions for Laboratory-Developed Tests
Looking for a quick way to design experiments?
Try the Workflow Configurator. A convenient tool to build experimental workflows and find products to match your needs.
Welcome to My QIAGEN
Dashboard
Account
Orders
Log Out
Resources
Home
Resources
new-fixation-technology-simultaneous-m...
New fixation technology for simlutaneous preservation of morphology and nucleic acids in tissue (EN)
PDF
(0.5 MB)
EN
EN
Download
Groelz et al., AMP 2008
